• Focus on Melanoma Virtual Meeting 15th October 2021

Focus on Melanoma Virtual Meeting 15th October 2021

We are delighted to announce that registration is now open for this year’s Focus on Melanoma Virtual Regional Meeting. The event is organised by Dr. Andrew Furness, The Royal Marsden Hospital

CME points will be applied from the Federation of the Royal Colleges of Physicians of the United Kingdom (RCP UK), the Royal College of Surgeons of England (RCS Eng) and the British Association of Plastic Reconstructive and Aesthetic Surgeons (BAPRAS).

If you are unsure about your membership, please contact Michelle at mbridge@melanomafocus.com.

2021 Registration Fees:

Early bird rate ends 17th September 2021

Member Early Bird Late Fee
Consultant £99 £149
Other Clinician / Student £69 £119
Nurse / AHP £34 £49
Non-Member
Consultant £159 £199
Other Clinician / Student £109 £154
Nurse / AHP £59 £79
Industry £249 £249

2021 Draft Programme:

09:00 – 09:15 Welcome/Introductions (Mark Harries / Imogen Cheese)
09:15 – 10:00 The Martin Gore Memorial Prize Lecture
Towards zero deaths from melanoma
Professor Georgina Long – Co-Medical Director/Chair of Melanoma Medical Oncology & Translational Research, Melanoma Institute of Australia/Royal North Shore Hospital, The University of Sydney
09:15 – 12:15 Pharma Exhibition Area
10:10 – 10:15 Virtual Networking x 4 concurrent (Surgeons/Dermatologists/Oncologists/CNS)

CNSs
Dermatologists
Oncologists
Surgeons

11:00 – 12:00 Industry Sponsored Symposium
12:30 – 12:40 Welcome
Dr Andrew Furness – Consultant Medical Oncologist/Team Leader, The Royal Marsden NHS Foundation Trust/Institute of Cancer Research
12:35 – 13:40 Session 1: COVID-19 and Cancer
Chair: Dr Samra Turajlic – Group Leader/Consultant Medical Oncologist, The Francis Crick Institute & Royal Marsden NHS Foundation Trust
12:35 – 13:00 The CAPTURE study – biological insights and implications for cancer patients
Dr Lewis Au, Senior Clinical Research Fellow – The Francis Crick Institute and Royal Marsden NHS Foundation Trust
13:00 – 13:25
Adjusting to the ‘new normal’ – lessons for the workplace learnt from a pandemic
Dr Claire Hardy – Occupational Psychologist and Senior Lecturer, Lancaster University
13:25 – 13:40 Q & A
13:40 – 14:45 Session 2: Novel loco-regional approaches
Chair: TBC
13:40 – 14:05 Modulation of local and systemic anti-cancer immunity via injectable therapies
Professor Kevin Harrington – Group Leader/Consultant Clinical Oncologist, The Institute of Cancer Research & Royal Marsden NHS Foundation Trust
14:05 – 14:30 The TITAN study – from bench to bedside: a surgical loco-regional interventional study
Mr Andrew Hayes – Consultant Surgical Oncologist/Team Leader, The Royal Marsden NHS Foundation Trust/Institute of Cancer Research
14:30 – 14:45 Q&A
   
14:45 – 14:55 Comfort Break
14:55 – 16:25 Session 3: Breakthrough systemic therapies
Chair: Dr Paul Nathan, Consultant Medical Oncologist, Mount Vernon Cancer Centre
14:55 – 15:20 Tebentafusp – a bi-specific antibody-based therapy for ocular melanoma
Dr Joe Sacco – Consultant Medical Oncologist/Clinical Senior Lecturer, The Clatterbridge Cancer Centre/University of Liverpool
15:20 – 15:45 Lifileucel – a tumour-infiltrating lymphocyte therapy for advanced melanoma
Dr Andrew Furness – Consultant Medical Oncologist/Solid Tumour Cellular Therapy Lead, The Royal Marsden NHS Foundation Trust/Institute of Cancer Research
15:45 – 16:10
Modulation of the gut microbiome for therapeutic gain
Professor Jennifer McQuade – Consultant Medical Oncologist/Physician-Scientist, MD Anderson Cancer Centre
16:10 – 16:25 Q&A
   
 16:25 – 17:20 Session 4: MDT – management of ano-uro-genital mucosal melanoma (case-based discussions)
Chair: Mr Myles Smith, Consultant Surgical Oncologist and General Surgeon, The Royal Marsden NHS Foundation Trust/Institute of Cancer Research
Panel:
Mr Asif Muneer, Consultant Urological Surgeon, University College London Hospitals
Mr Desmond Barton, Consultant Gynaecologist Oncologist, Royal Marsden Hospital
Professor James Larkin, Consultant Medical Oncologist, Royal Marsden Hospital
17:20 – 17:30 Concluding Remarks and Close
Dr Mark Harries, Chairman Melanoma Focus, Dr Andrew Furness, Organiser
Imogen Cheese, Melanoma Patient Conference

printer-friendly version